This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Assistance Publique-Hopitaux De Paris, Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2025.
Company Filing History:
1 out of 331 
1 out of 5,383 
1 out of 1,853 
Years Active: 2025
Title: Muriel Girard: Innovator in Biliary System Treatment
Introduction
Muriel Girard is a notable inventor based in Issy Les Moulineaux, France. She has made significant contributions to the field of neonatal cholestasis, particularly in the treatment of diseases associated with biliary system destruction. Her innovative work has the potential to impact the lives of many affected by these conditions.
Latest Patents
Muriel Girard holds 1 patent related to the treatment of neonatal biliary atresia and diseases associated with biliary system destruction. This patent encompasses methods and compounds aimed at treating or preventing biliary atresia, as well as slowing the progression of the disease. Her research addresses critical challenges in neonatal health and offers promising solutions.
Career Highlights
Throughout her career, Muriel has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and the National Institute of Health and Medical Research. These experiences have allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.
Collaborations
Muriel has collaborated with Ganna Panasyuk, a fellow researcher, to advance their understanding and treatment of biliary system diseases. Their partnership exemplifies the importance of teamwork in scientific innovation.
Conclusion
Muriel Girard's contributions to the treatment of biliary system diseases highlight her dedication to improving neonatal health. Her innovative approaches and collaborations continue to pave the way for advancements in medical research and treatment options.